Avalo Therapeutics, Inc. · NASDAQ:AVTX

BVF PARTNERS L P/IL reported a 9.99% stake in Avalo Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

BVF PARTNERS L P/IL reported a 9.99% stake in Avalo Therapeutics, Inc., 1,904,257 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.99%
Shares
1,904,257
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P6.80%1,286,909
BVF I GP LLC6.80%1,286,909
BIOTECHNOLOGY VALUE FUND II LP2.70%500,507
BVF II GP LLC2.70%500,507
Biotechnology Value Trading Fund OS LP0.50%97,524
BVF Partners OS Ltd.0.50%97,524
BVF GP HOLDINGS LLC9.40%1,787,416
BVF PARTNERS L P/IL9.99%1,904,257
BVF INC/IL9.99%1,904,257
LAMPERT MARK N9.99%1,904,257

Source

View original at SEC

Related